KDE07702
Colorimetric
Plasma, Serum
Quantitative
78.125 - 5,000 ng/mL
33.12 ng/mL
CV<20%
80-120%
2-8 ℃
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
IMA-638, CAS: 910649-32-0
Mapping knowledge structure and research of the biologic treatment of asthma: A bibliometric study., PMID:36845128
The role of interleukin-13 in chronic inflammatory intestinal disorders., PMID:30844559
Modulating Interleukins and their Receptors Interactions with Small Chemicals Using In Silico Approach for Asthma., PMID:30068279
A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma., PMID:27637004
A mechanistic PK/PD model for two anti-IL13 antibodies explains the difference in total IL-13 accumulation observed in clinical studies., PMID:27049478
A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients., PMID:25614144
Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study., PMID:25567115
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
